Overall one-year survival was over 85 percent for high-risk or inoperable patients who underwent aortic valve replacement with the SAPIEN 3 trans-catheter aortic valve replacement system, according to a study published in the July 12 issue of the American Heart Association journal Circulation. This survival rate is strikingly higher compared to patient outcomes reported in studies that used older trans-catheter aortic valve replacements (TAVR) systems.
↧